Detalles de la búsqueda
1.
Pharmacological evaluation of novel (6-aminopyridin-3-yl)(4-(pyridin-2-yl)piperazin-1-yl) methanone derivatives as TRPV4 antagonists for the treatment of pain.
Bioorg Med Chem
; 25(7): 2177-2190, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28284871
2.
Suppression of the acute upregulation of phosphorylated-extracellular regulated kinase in ventral tegmental area by a µ-opioid receptor agonist is related to resistance to rewarding effects in a mouse model of bone cancer.
J Pharmacol Sci
; 133(1): 9-17, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28034513
3.
Discovery of novel 2',4'-dimethyl-[4,5'-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 2.
Bioorg Med Chem Lett
; 26(20): 4936-4941, 2016 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27634196
4.
Discovery of novel 2',4'-dimethyl-[4,5'-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 1.
Bioorg Med Chem Lett
; 26(20): 4930-4935, 2016 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27637151
5.
Sensitization of transient receptor potential vanilloid 4 and increasing its endogenous ligand 5,6-epoxyeicosatrienoic acid in rats with monoiodoacetate-induced osteoarthritis.
Pain
; 159(5): 939-947, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438227
Resultados
1 -
5
de 5
1
Próxima >
>>